| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.6779977674512907 3.7965901950036702 0.0001467000027377 0.0839946163818755 0.0438633008185887 46 O75306,O75964,P00403,P13073,P14406,P21912,O14949,O43676,P56385,O96000,O95168,P31930,P06576,Q9UDW1,P12235,P22695,O75880,Q9Y6M9,P20674 19 |
| Nonalcoholic fatty liver disease 0.597201365914927 3.2285788952356897 0.0012440693758242 0.5249886762623848 0.1050429907876768 52 O43676,Q9P0J0,O75306,O95168,Q96J02,Q9UDW1,Q9Y478,Q86Y39,P00403,P13073,P14406,P22695,P21912,O96000,Q9Y6M9,P54646,P31930,O14949 18 |
| Sphingolipid metabolism integrated pathway 0.8926536707188916 2.829802426263484 0.0046576756935321 0.9386890465222394 0.1050429907876768 9 Q96G23,Q9NRA0,P27544,Q06136,Q16739,Q13510,O95470 7 |
| Sphingolipid metabolism overview 0.8926536707188916 2.829802426263484 0.0046576756935321 0.9386890465222394 0.1050429907876768 9 Q96G23,Q9NRA0,P27544,Q06136,Q16739,Q13510,O95470 7 |
| Sphingolipid metabolism in senescence 0.8198495892052208 2.8208181535101877 0.0047901347869931 0.943379448708636 0.1050429907876768 12 Q96G23,P04062,Q06136,Q16739,Q13510,P16278 6 |
| Sphingolipid pathway 0.858536317936066 2.816287479041882 0.0048582173202975 0.9456490930358772 0.1050429907876768 10 Q96G23,Q9NRA0,P04062,Q06136,Q16739,Q13510,O95470 7 |
| Ferroptosis 0.6324020716427062 2.581661209162065 0.0098326056853725 0.997285089953901 0.1507666205090463 24 Q9Y277,P45880,P37268,P16435,P09601,P04035 6 |
| Mitochondrial complex iv assembly 0.7602335492586435 2.351564424483435 0.018694651964104 0.9999874428494422 0.2219480586444642 10 Q9Y2R0,P00403,P13073,P14406 4 |
| Oxidation by cytochrome p450 0.8733410064326517 2.3469325590013557 0.0189286805867352 0.9999891120355392 0.2219480586444642 6 P16435,Q6UW02,O43169 3 |
| Mecp2 and associated rett syndrome 0.5977950728901724 2.280916248006201 0.0225534032980683 0.9999988097526852 0.2544704749480161 22 P52597,Q05086,Q99640,P31943,P67809,P35637,Q03518 7 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5834754993211299 2.254100250595215 0.0241898619178098 0.9999995630166764 0.2630097713972775 24 Q15392,Q14739,Q16850,P37268,Q14534,Q15125,Q15800,P04035 8 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8447935308569812 2.227211784399352 0.025933122906812 0.9999998500012084 0.2769287053263143 6 Q15125,Q15392,Q16850,Q14739 4 |
| Glycosaminoglycan degradation 0.8372521557581121 2.195302117927738 0.0281419330891696 0.999999961407702 0.2952434383740959 6 P54802,P16278,P08236,P15586 4 |
| Oxidative phosphorylation 0.5514534908180769 2.1463940609737997 0.0318415527616502 0.9999999960556945 0.3071169121204329 27 O75306,O75964,Q86Y39,P56385,O96000,Q9Y6M9,O95168 7 |
| Statin inhibition of cholesterol production 0.8752458568314453 2.107233612214851 0.0350973347190921 0.9999999994738172 0.313256808388315 5 Q8WTV0,P37268,P04035 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.8611024602927227 2.049488038049045 0.040414416349144 0.9999999999806776 0.3310660407779193 5 Q06136,Q16739,Q9NRA0,O95470 4 |
| Mitochondrial complex iii assembly 0.6908322489405732 2.006632633942126 0.0447887938492919 0.9999999999987428 0.3571159829583542 10 Q9UDW1,Q6DKK2,P22695,O14949,P31930 5 |
| Familial partial lipodystrophy fpld 0.7488515885497895 1.9580468486971936 0.0502245156855369 0.9999999999999586 0.3798207275275477 8 O60725 1 |
| Progeriaassociated lipodystrophy 0.6383015816428452 1.858932062713493 0.0630367687022306 1.0 0.457951182959228 11 O75844,O60725 2 |
| Mitochondrial complex i assembly model oxphos system 0.5218230505434176 1.855241231096863 0.0635617862635717 1.0 0.457951182959228 25 O43676,Q9P0J0,O96000,Q9Y6M9,Q96CU9 5 |
| Copper homeostasis 0.7098023470896548 1.7766836908773846 0.0756202971373416 1.0 0.4831933891359897 8 O75880,P35670 2 |
| Proteoglycan biosynthesis 0.7397334809123975 1.7721860866606576 0.0763636724203855 1.0 0.4831933891359897 6 Q96L58,Q8TB61,Q8NCH0,Q93063 4 |
| Cholesterol biosynthesis pathway 0.6111404717912943 1.7696169010675122 0.0767909814277727 1.0 0.4831933891359897 13 Q16850,P37268,Q14534,Q15800,P04035 5 |
| Striated muscle contraction pathway 0.7324732251580044 1.7399354465700456 0.0818703536692142 1.0 0.4995762397366338 6 P08670 1 |
| Ethanol effects on histone modifications 0.5956937441568377 1.6539532699757666 0.0981370078086836 1.0 0.5702462587875091 12 P00374,P41440 2 |
| S1p receptor signal transduction 0.6396791210279071 1.628707097202028 0.1033750396079129 1.0 0.5723914230141847 9 P31749,Q9NRA0,Q13510,P31751,P04899 5 |
| Degradation pathway of sphingolipids including diseases 0.7150056900582207 1.6212901179817465 0.1049554333686793 1.0 0.5758105427015616 7 P06280,P06865,O43681,P17900,P16278 5 |
| Omega3 omega6 fatty acid synthesis 0.7005102408684944 1.596830128778849 0.110303578025849 1.0 0.5837304394642274 6 O15254,Q15067 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.5747583643735397 1.5639086994273674 0.1178390112231513 1.0 0.6127628583603868 13 Q16836,Q9BY49,P23786 3 |
| Kennedy pathway from sphingolipids 0.740076420774139 1.5421500227977123 0.1230371415252375 1.0 0.6162261268250953 5 P35790,Q9UG56,O95470 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.6010293959482103 1.539601921786952 0.1236574167541997 1.0 0.6162261268250953 10 Q9NR77,Q9UI14,O60333 3 |
| Influence of laminopathies on wnt signaling 0.5741850305872979 1.5335020276429725 0.125152207442871 1.0 0.6185208268664205 12 O75844,P48729,Q5JTV8,P50402,O60725 5 |
| Nad biosynthetic pathways 0.731031577298333 1.5034152134769732 0.1327320058882428 1.0 0.6200477328604653 5 P43490 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5191237424463949 1.4877884059109856 0.1368067042334062 1.0 0.6200477328604653 17 O75844,P48729,P42167,P50402,O60725,P55209 6 |
| 1q211 copy number variation syndrome 0.5899357122707473 1.4804216895613398 0.1387607452301733 1.0 0.6200477328604653 10 Q9Y478,Q9NPH0 2 |
| Ccl18 signaling pathway 0.6097147972049941 1.4754439483362176 0.1400932272458004 1.0 0.6200477328604653 9 P00403,P08670 2 |
| Metapathway biotransformation phase i and ii 0.4651269854594286 1.3816011109398811 0.1670942126912113 1.0 0.6706197261029826 23 Q9NRB3,Q6UW02,Q16850,Q7LGA3,Q8NCH0,P21964,P07099 7 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8144231144603085 1.3393633109741376 0.1804524272794072 1.0 0.693043162412474 4 P07099 1 |
| Irinotecan pathway 0.8462974486621081 1.3383147104949955 0.180793868455428 1.0 0.693043162412474 2 O15118 1 |
| Mitochondrial immune response to sarscov2 0.5790814681808585 1.3168673885125453 0.1878830794623001 1.0 0.7000549238654858 9 Q9BQ95,Q99623,Q9Y276,Q9Y6M9,Q7Z434,P35232 6 |
| Ketogenesis and ketolysis 0.6375953832424981 1.3106067795757224 0.1899906475643027 1.0 0.7000549238654858 6 P23786 1 |
| Urea cycle and related diseases 0.8279402613565738 1.2620011778652138 0.2069483625420378 1.0 0.728006846751806 2 Q9Y619 1 |
| Genes related to primary cilium development based on crispr 0.5194384938547985 1.2439237769485991 0.2135276175114331 1.0 0.7418662451011221 13 Q10713 1 |
| Vitamin d metabolism 0.8649237472766822 1.2241983551885778 0.2208774095267505 1.0 0.7420488252640269 3 P04062,P38435 2 |
| Spinal cord injury 0.4464443789547692 1.18552833278817 0.2358086192209458 1.0 0.7609700722516053 20 Q9NQC3,P04083,P08670 3 |
| Nad metabolism 0.7738426234458796 1.1813387491020382 0.2374681797693381 1.0 0.7609700722516053 4 P43490 1 |
| Folate metabolism 0.5067997562620162 1.1698760551443723 0.2420508512256893 1.0 0.7609700722516053 13 Q8WTV0,P00374,P41440 3 |
| Nephrotic syndrome 0.5065659517207776 1.1685038847332914 0.2426035731856184 1.0 0.7609700722516053 13 Q14108 1 |
| Canonical and noncanonical notch signaling 0.8042937149968941 1.16421570909277 0.2443366056080906 1.0 0.761006719550199 2 P55081 1 |
| Serotonin and anxiety 0.7906036092097083 1.1079787160590862 0.2678710079707382 1.0 0.783609901674222 2 Q06787 1 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.78811449906659 1.0977902784539024 0.2722960774734397 1.0 0.783609901674222 2 P00367 1 |
| Zinc homeostasis 0.8272642390289414 1.0840236837650736 0.2783542979754965 1.0 0.7909065115195801 3 Q8TAD4,Q15043 2 |
| Pkcgamma calcium signaling pathway in ataxia 0.7812694461729917 1.0698367858949454 0.2846927810387782 1.0 0.8030485050056104 2 Q15118 1 |
| Mthfr deficiency 0.5766543458716834 1.0302590019711897 0.302888439139001 1.0 0.8273589808214941 6 P35790 1 |
| Endothelin pathways 0.5545071809822929 1.0275726544585275 0.3041508928831535 1.0 0.8273589808214941 8 P00403,P42892 2 |
| Inclusion body myositis 0.8079077058812267 1.0126307321929549 0.31123657489452 1.0 0.8312907750712889 3 P05067 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4832348595321636 1.0123169959386216 0.3113865110634928 1.0 0.8312907750712889 12 O75718,P07237,Q96AY3 3 |
| Relationship between inflammation cox2 and egfr 0.601645517317853 0.945110236878508 0.3446025996096495 1.0 0.8526644871149691 5 P31751,P31749,Q9H7Z7 3 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4741022036665363 0.9435826520640374 0.3453829606991094 1.0 0.8526644871149691 11 P37268 1 |
| Allograft rejection 0.4730940070242546 0.9378454829925436 0.3483238232020902 1.0 0.8526644871149691 11 P08183,Q9BY49,P10321,P08670 4 |
| Vitamin b12 metabolism 0.5564432208897505 0.9374698632810816 0.348516918708146 1.0 0.8526644871149691 6 Q8WTV0 1 |
| Alzheimers disease and mirna effects 0.3255670537972496 0.9317478966101426 0.3514668272450334 1.0 0.8526644871149691 86 P21796,P16615,Q9NQC3,P45880,P20618,P48556,P28074,P28072,Q08209,Q8NE86,Q9Y277,Q9UJX6,P31751,P28070,O00459,P12235,P49720,P05067,O95197,Q96IX5,P12236,O15111,P49721,Q92542 24 |
| Ppar signaling pathway 0.4377518040915375 0.8900117338842781 0.3734595855417162 1.0 0.8625591313011423 16 O15254,P23786 2 |
| Congenital generalized lipodystrophy cgl 0.7314872433105206 0.8702748229669756 0.3841502344720846 1.0 0.8646595147300357 2 P31751 1 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.4911698755482488 0.8566225159289287 0.391653537969991 1.0 0.8706647424016901 9 Q12834,Q9UJX6 2 |
| Triacylglyceride synthesis 0.576816588050142 0.8392885661096662 0.401307397876808 1.0 0.8801845887160098 5 Q9HCL2 1 |
| Alzheimers disease 0.3180414457164197 0.8147272488446438 0.4152284522848453 1.0 0.8964137706365973 85 P21796,P16615,Q9NQC3,P45880,P20618,P48556,P28074,P28072,Q08209,Q8NE86,Q9Y277,Q9UJX6,P31751,P28070,O00459,P12235,P49720,P05067,O95197,P12236,O15111,P49721,Q92542 23 |
| Glycerolipids and glycerophospholipids 0.5617765318160381 0.7759302924917817 0.437790145405841 1.0 0.9194038493448564 5 Q9HCL2 1 |
| Heme biosynthesis 0.6644662226583891 0.7635670104416413 0.4451253148621372 1.0 0.9194038493448564 4 P36551,P22830 2 |
| Adipogenesis 0.4143632939513082 0.740962791326775 0.4587160013399027 1.0 0.9194038493448564 16 O75844 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.6854387056627296 0.6943687928089823 0.4874509593198342 1.0 0.9352343286226116 2 Q7Z434 1 |
| Neuroinflammation 0.538948913729619 0.6812567288033202 0.4957090581787469 1.0 0.9352343286226116 5 P00403 1 |
| Circadian rhythm genes 0.3312712109215254 0.6749073432636178 0.4997346347935907 1.0 0.9352343286226116 44 Q8WXF1,Q05086,Q9NRV9,P54802,P43490,Q9BWF3,Q14103,Q03164,P54646,P00813 10 |
| 15q112 copy number variation syndrome 0.6385088115172508 0.6688554117982736 0.5035877154121755 1.0 0.9352343286226116 4 Q7L576,Q06787 2 |
| Tryptophan metabolism 0.4090945143492108 0.6561052187713199 0.5117564268143429 1.0 0.9403987300927832 15 Q16836,Q15392,P51648 3 |
| Selenium micronutrient network 0.4368684962200144 0.6508226815024761 0.5151609569571258 1.0 0.9403987300927832 10 Q8WTV0,Q99707,P00390 3 |
| Orexin receptor pathway 0.4035290773682907 0.6223286425550112 0.5337257909462121 1.0 0.9411746227507356 15 Q8TDW0,O60313,P50336,O00459,Q13595 5 |
| Retinoblastoma gene in cancer 0.3260233824872678 0.620215366141289 0.5351160062462377 1.0 0.9411746227507356 47 P00374,Q9Y619 2 |
| Estrogen receptor pathway 0.6870730060574537 0.5894533800391576 0.5555571770410803 1.0 0.9629657735378726 3 Q9HCL2 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6810173648518825 0.569869171494394 0.5687664356552562 1.0 0.9642219621391184 3 P48729 1 |
| T cell receptor and costimulatory signaling 0.4810712404202531 0.5623688044358249 0.5738647688452514 1.0 0.9642219621391184 7 P48729,Q08209,P31749,Q15118 4 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3373739449931352 0.5269626794922664 0.5982195054197916 1.0 0.9653183537810192 34 Q8WTV0,Q9HCL2,Q16850,P37268,Q14534,P04035 6 |
| Glycerophospholipid biosynthetic pathway 0.4485414332426052 0.5196333336340775 0.6033191604196215 1.0 0.9653183537810192 8 Q9Y6K0,O00116,Q9HCL2,Q9BTU6 4 |
| Target of rapamycin tor signaling 0.3915139244055218 0.4984468125879793 0.6181691486490666 1.0 0.968305581857156 13 P04035,Q9Y478,P62942 3 |
| Preimplantation embryo 0.459038794791509 0.4690022225907744 0.6390680473423505 1.0 0.97322056655131 7 Q99729,Q92945 2 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.6467475879240516 0.463419497747267 0.6430637055693027 1.0 0.97322056655131 3 P31749,P42345 2 |
| 7oxoc and 7betahc pathways 0.3988409957066096 0.4530405217930608 0.650519562939297 1.0 0.974821559600381 10 O15118,Q9UBM7,O14734,P61916,Q15125 5 |
| Cellular proteostasis 0.4789785113671775 0.4458195737964198 0.6557275815346351 1.0 0.974821559600381 5 P61758,Q9NQP4,Q9UHV9,Q99471 4 |
| Immune response to tuberculosis 0.4773946673069215 0.4399553980197491 0.6599694115039054 1.0 0.974821559600381 5 O75925,Q03518 2 |
| Purinergic signaling 0.5694271481942699 0.4337166147206178 0.6644942399595957 1.0 0.974821559600381 4 Q96RD7,P04899,P08754 3 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.4497369554939533 0.430646008402498 0.6667257824022672 1.0 0.974821559600381 7 P31749,Q07820,Q9BXK5 3 |
| Proximal tubule transport 0.3923700706250017 0.4205404682790548 0.6740906727482465 1.0 0.9799679380331786 10 P05023,P08183,P04920,P08195 4 |
| Nanomaterial induced apoptosis 0.428436227190298 0.3457104762999367 0.7295603102474912 1.0 0.9891606342704063 7 O95831,Q9NR28 2 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.426197857233756 0.3370475252288191 0.7360810739972088 1.0 0.9891606342704063 7 P31749,O00459,P42345,P49841,Q15118 5 |
| Interactions between loxl4 and oxidative stress pathway 0.533312577833124 0.3247919251897773 0.7453385562865575 1.0 0.9897641436684969 4 Q16543,Q9BQ95,Q96EB6 3 |
| Primary focal segmental glomerulosclerosis fsgs 0.3321761675813008 0.3206209750107351 0.7484976403809611 1.0 0.9897641436684969 18 Q14108 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3732319653549211 0.2758891302577013 0.7826332228374309 1.0 0.9941710044509556 9 P31749,Q15118,P42345,P49841,Q9Y478 5 |
| Vitamin d receptor pathway 0.34748965226048 0.267339484928658 0.7892077881283421 1.0 0.9941710044509556 14 Q92604,P20020,Q96KA5,Q5VV42,P08183 5 |
| Riboflavin and coq disorders 0.5121111909708512 0.266720555247652 0.789684326277933 1.0 0.9941710044509556 4 Q16134,Q8NI60 2 |
| Mitochondrial gene expression 0.4227314500578421 0.2534188906674986 0.7999445313507179 1.0 0.9984053702072756 5 Q08209,O00411,Q9P2K5 3 |
| G1 to s cell cycle control 0.3074422573835994 0.2483516204583146 0.8038623623784076 1.0 0.9984053702072756 29 Q9Y619 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3419748194979353 0.238970211153767 0.8111286816580823 1.0 1.0 14 P54646,P31751,Q05086,Q9Y478 4 |
| Neovascularisation processes 0.5242688238954608 0.2157252414007235 0.8292019246557478 1.0 1.0 2 P31749 1 |
| Vitamin dsensitive calcium signaling in depression 0.3870364599563797 0.1953068694460917 0.8451527195877329 1.0 1.0 7 P23634,P20020,P11413,P00390,O60341,Q8NB78 6 |
| Male infertility 0.3048947791314774 0.1946384719022613 0.8456759827837312 1.0 1.0 21 Q15165,P08183,P41440 3 |
| Aryl hydrocarbon receptor pathway wp2873 0.3973839925256955 0.1796544580233097 0.8574238488383903 1.0 1.0 5 Q16543,P12931,P07900,O00170 4 |
| Amyotrophic lateral sclerosis als 0.3403446439627465 0.178695072586126 0.8581771384180699 1.0 1.0 10 P07197,Q08209,Q9BUN8,O96008 4 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.3490659836395819 0.1747866843000111 0.8612472516604279 1.0 1.0 9 Q8IXH7 1 |
| Erk pathway in huntingtons disease 0.5244319950202362 0.1666917182407742 0.8676126222509377 1.0 1.0 3 P42858,P55210 2 |
| Glycosylation and related congenital defects 0.3354287072840373 0.1581342986149807 0.8743509742404827 1.0 1.0 10 Q9BT22,Q2TAA5 2 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.3248505833707771 0.1545077062820199 0.8772094354487219 1.0 1.0 14 P43490 1 |
| Mrna processing 0.2809655613324691 0.1411991165147961 0.8877126440026912 1.0 1.0 106 P61978,O43390,Q01130,Q99729,P35637,Q86U42,Q07955,P22626,Q13243,P07910,Q13242,O60942,P31943,Q92620,Q5KU26,P38159,O75494,P55795,Q15233,P67809,P62995,Q16629,P52756,Q14103,P23246 25 |
| Fatty acid betaoxidation 0.2941377636965646 0.1306346315022591 0.8960643454964452 1.0 1.0 19 Q16836,Q9UKU0,P40939,P23786 4 |
| Fatty acid transporters 0.3780753659296192 0.1299574453634079 0.8966000947716448 1.0 1.0 5 P33121,Q9UKU0,O60488,O95573 4 |
| Hostpathogen interaction of human coronaviruses autophagy 0.491441020852784 0.1143715082250527 0.9089432989076784 1.0 1.0 3 Q99570,P42345 2 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.3709124883213978 0.1130462384268857 0.9099938971758864 1.0 1.0 5 P06753,P61201,O15111,P18031 4 |
| Interactome of polycomb repressive complex 2 prc2 0.4885076027907241 0.1103265039728243 0.91215043843334 1.0 1.0 3 Q9NYF8 1 |
| Nodlike receptor nlr signaling pathway 0.4811541944839702 0.1006154728241888 0.9198557135023844 1.0 1.0 3 O15111 1 |
| Nanoparticle triggered autophagic cell death 0.4305728518057264 0.0928191285860593 0.9260472541994418 1.0 1.0 4 Q13111,Q9NT62,P49815 3 |
| Urea cycle and associated pathways 0.3085227452406877 0.0808004212839795 0.9356006730307134 1.0 1.0 13 P04181,P00367,Q9Y619 3 |
| Sars coronavirus and innate immunity 0.4595704428756578 0.0755719101788904 0.9397596849681182 1.0 1.0 3 P23458 1 |
| Sulfation biotransformation reaction 0.4522253345782792 0.0681865251531216 0.9456371533757776 1.0 1.0 3 P00390,P11413 2 |
| Disruption of postsynaptic signaling by cnv 0.3299267492598603 0.0620366223232093 0.9505336677574696 1.0 1.0 6 Q14168,Q06787 2 |
| Dna replication 0.2814242788805371 0.057869583356877 0.9538525114694644 1.0 1.0 31 Q9Y619,Q14566 2 |
| Tgfbeta receptor signaling 0.3418233509887819 0.0532063481085712 0.9575674977226244 1.0 1.0 5 P62942 1 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.3418233509887819 0.0532063481085712 0.9575674977226244 1.0 1.0 5 P62942 1 |
| Notch signaling 0.3199376947040575 0.0389381056443685 0.9689397356826251 1.0 1.0 6 P56545,Q13547,Q92769,Q92542,Q13363 5 |
| Robo4 and vegf signaling pathways crosstalk 0.3937130407718653 0.0274182328717206 0.978126155986472 1.0 1.0 3 P12931,O94813 2 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.3392468098350466 0.0110639123694037 0.9911724552356008 1.0 1.0 3 P28482,O15111 2 |
| P53 transcriptional gene network 0.3106680484998686 0.0058051386103008 0.9953681955445544 1.0 1.0 8 P04066 1 |
|
|
